Table 3.
Variables | Overall survival | Time to leukemic change | ||||||
---|---|---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |||
Lower | Upper | Lower | Upper | |||||
Agea | 1.019 | 1.003 | 1.035 | 0.017* | 0.984 | 0.965 | 1.005 | 0.133 |
IPSS-Rb | 3.114 | 1.839 | 5.270 | <0.001* | 3.694 | 1.710 | 7.982 | 0.001* |
SRSF2 | 1.092 | 0.501 | 2.379 | 0.825 | 0.913 | 0.294 | 2.837 | 0.875 |
ZRSR2 | 1.400 | 0.665 | 2.950 | 0.376 | 0.690 | 0.212 | 2.242 | 0.537 |
ASXL1 | 1.628 | 0.784 | 3.381 | 0.191 | 4.788 | 1.933 | 11.857 | 0.001* |
EZH2 | 1.227 | 0.456 | 3.300 | 0.685 | 0.701 | 0.171 | 2.881 | 0.622 |
TP53 | 4.563 | 1.936 | 10.753 | 0.001* | 5.009 | 1.250 | 20.079 | 0.023* |
Aberrant AS scorec | 1.801 | 1.019 | 3.181 | 0.043* | 2.736 | 1.036 | 7.222 | 0.042* |
HR hazard ratio, CI confidence interval
*Statistically significant (P < 0.05)
aAge as a continuous variable
bIPSS-R risk score > 4.5 relative to IPSS-R ≤ 4.5 (the reference)
cHigh global aberrant AS score relative to low global aberrant AS score (the reference)